Kebijakan Kemenkes sesuai rekomendasi WHO tentang PPI TB meliputi 4 pilar yaitu manajerial, pengendalian administratif, pengendalian lingkungan dan pengendalian perlindungan diri.

Our finding that PPIs limit Mtb intramacrophage growth in the absence of antibiotics raises the question of whether existing epidemiological data point to their protective effect against TB. …

Jul 19, 2017 · On the other words, PPI therapy should be withheld from patients with highly suspect pulmonary TB, even not prescribed PPI before confirm diagnosis of pulmonary TB. In …

Aug 1, 2019 · In three case-control studies, compared with non-PPI use, PPI use was associated significantly with TB incidence, a 1.2-to-1.7-fold increased risk (adjusted OR 1.29; 95%CI 1.29 …

Nov 21, 2017 · In this study, use of the commonly prescribed and cheaply available PPI lansoprazole was associated with reduced incidence of TB disease. Given the serious problem …

Jul 9, 2015 · Here, by testing a panel of FDA-approved drugs in a host cell-based assay, we show that the blockbuster drug lansoprazole (Prevacid), a gastric proton-pump inhibitor, has …

In this case-control study, we found that recent PPI use and continuous PPI use were associated with increased tuberculosis development. Although further investigation is needed, the …

Feb 14, 2023 · Like verapamil, the PPIs inhibit macrophage-induced rifampicin tolerance as well as intramacrophage growth, which has also been linked to mycobacterial efflux pump activity. …

Aug 1, 2019 · In three case-control studies, compared with non-PPI use, PPI use was associated significantly with TB incidence, a 1.2-to-1.7-fold increased risk (adjusted OR 1.29; 95%CI …

Jan 1, 2025 · Acid-suppressant proton-pump inhibitors (PPI) and histamine-2-receptor antagonists (H2RA) are associated with an increased risk of tuberculosis (TB). However, it …